Medical Marijuana Coming Soon to Virginia

On the heels of decriminalization and legalizing medical marijuana, Virginia’s first dispensary is set to open in August 2020. Through the current system of licensing, only five vertically-integrated entities will operate within the state initially – with Dharma representing the first scheduled opening. Initial profit predictions are middling, as Virginia will allow only a small subset of marijuana-based products at…

Read More

HEXO Finds a New Market: Should Cannabis Investors Celebrate?

Cannabis producer HEXO (TSX:HEXO)(NYSE:HEXO) announced its first-ever product export to Israel on Thursday. The company has finally found a new market for medical marijuana after several quarters of declining segment sales. A recovering HEXO stock surged more than 5% on the news as investors took notice. However, should the market celebrate this latest win? What happened? HEXO has entered a 24-month…

Read More

TFSA Investors: Buy Aphria (TSX:APHA) Stock

Cannabis grower and leading distributor Aphria’s (TSX:APHA)(NYSE:APHA) stock price could continue to surge and outperform industry peers in 2020, and I’m maintaining my positive outlook and reiterating a buy recommendation on this marijuana firm. In a November 2019 post, and while discussing three potential buys for 2020, I likened the stock’s potential payoff to that on a cannabis lottery ticket.…

Read More

GCAC Introduces Cannabis 3.0

Closing the Medical Cannabis Value Chain Loop by Michael Kryton, EQUITY IR contributing writer GCAC (CSE: APP, FSE: 2FA), the winner of the 2019 A.I of the Year Award at the prestigious 2019 Malta Medical Cannabiz Awards in early November, continues to push innovation in the medical cannabis sectors to new levels. They refer to their new vision as Cannabis…

Read More

3 Takeaways From Canopy Growth’s (TSX:WEED) Horrible Quarterly Earnings

Leading marijuana growth stock Canopy Growth (TSX:WEED)(NYSE:CGC) released its anticipated fiscal second quarter 2020 results early on Thursday. In the midst of the largely bad news report were some small grains of hope-inducing numbers. Second-quarter gross revenue had grown 6% sequentially quarter over quarter to a respectable $118.3 million, but there were some necessary charges to the revenue line of…

Read More

Key Takeaways From Aurora Cannabis’ (TSX:ACB) Fourth-Quarter Results

Canada’s top pot company, Aurora Cannabis (TSX:ACB)(NYSE:ACB) announced its fiscal fourth quarter of 2019 (ended in June) results after market close on September 11, 2019. The company reported revenue of $98.9 million, a rise of 52% sequentially and 416% year over year. The company’s net cannabis sales grew 61% sequentially to $94.6 million. Canadian consumer sales were up 52% at…

Read More

Marijuana Stock Investors: Don’t Miss Out on This IPO

Would the initial public offering of Breath of Life International be the most explosive IPO when the company finally lists on the TSX? Israel’s largest medical cannabis producer is known more as BOL Pharma in its home country. You shouldn’t miss on out on this marijuana IPO, as the company could be the global leader in medical cannabis. As of…

Read More

Medical Cannabis, Blockchain and AI

How Global Cannabis Application Corp is innovating the Internet of Cannabis by Michael Kryton, EQUITY IR contributing writer According to Brad Moore, CEO of Global Cannabis Application Corp (GCAC), the world view of cannabis is evolving beyond the perception of marijuana as it has been perceived (a recreational solution delivered via a joint, reefer, fatty, pot, ) to what it…

Read More

This Colombian Girl-Boss Leads Medical Cannabis

Last year, Canopy Growth (TSX:WEED)(NYSE:CGC) announced the acquisition of the leading Colombian medical marijuana company, Spectrum Cannabis. According to an SEC filing dated February 14, 2019, Spectrum Cannabis owns 126 hectares of land on which Canopy Growth may cultivate legal marijuana. Spectrum Cannabis began as a family-owned medical cannabis company in Colombia following medical marijuana’s legalization in 2016. Post-acquisition, Bibiana…

Read More

Should You Invest in Breath of Life International’s Weed Stock IPO?

Over the years, Israel has played a leading role in the development of medical marijuana. THC–the psychoactive compound in marijuana–was first isolated by Israeli chemists in 1964 and later developed by Israeli companies for use in their own country. After achieving popularity as a cancer treatment in the 1990s, THC was officially approved for export by Israeli authorities. Now, Israel…

Read More